Delay in radiotherapy shortens survival in patients with high grade glioma

Journal of Neuro-Oncology

Volumn 85, Issue 3, 2007, Pages 339-343

  Irwin, Chris ^a   Hunn, Martin ^a   Purdie, Gordon ^b   Hamilton, David ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Glioblastoma multiforme; High grade glioma; Radiotherapy; Survival; Treatment delay

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL TIME; THERAPY DELAY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; REGRESSION ANALYSIS; RESOURCE ALLOCATION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 36349004127     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9426-z     Document Type: Article

References (11)

1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
2. Anonymous (1990) Prognostic factors for high-grade malignant glioma: development of a prognostic index. A report of the medical research council brain tumour working party. J Neurooncol 9:47-55
3. Lin D, Wei L, Ying Z (1993) Checking the cox model with cumulative sums of martingale-based residuals. Biometrika 80:557-572
4. Richards MA, Westcombe AM, Love SB et al (1999) Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353:1119-1126
5. Fazeny-Dorner B, Wenzel C, Veitl M et al (2003) Survival and prognostic factors of patients with unresectable glioblastoma multiforme. Anti-Cancer Drugs 14:305-312
6. Fazeny-Dorner B, Gyries A, Rossler K et al (2003) Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center. Wien Klin Wochenschr 115:389-397
7. Kleinberg L, Grossman S, Piantadosi S et al (1999) The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys 44:535-543
8. Do V, Gebski V, Barton MB (2000) The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57:131-136
9. Burnet N, Jena R, Jefferies SJ et al (2006) Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol 18:93-103
10. Walker M, Strike T, Sheline GE et al (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731
11. Bleehen NM, Stenning SP (1991) Medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The medical research council brain tumour working party. Br J Cancer 64:769-774